Fig. 2
- ID
- ZDB-FIG-110718-13
- Publication
- Becker et al., 2011 - Human cardiomyopathy mutations induce myocyte hyperplasia and activate hypertrophic pathways during cardiogenesis in zebrafish
- Other Figures
- All Figure Page
- Back to All Figure Page
TNNT2sp morphants have reduced ventricular dimensions and impaired ventricular function. (A) Comparison of control-injected (top) and TNNT2sp morphant (bottom) embryos at 96 hpf. (B) Representative high-magnification image of control (left) and TNNT2sp morphant (right) heart (A, atria; V, ventricle; atria not visible in control). (C) Chamber dimensions in control (black bar) and TNNT2sp morphants (gray bar). (D) FS in control (black bar) and TNNT2sp morphants (gray bar). *P<0.05; n=5 for all measurements. All data expressed as mean + s.e.m. |
Fish: | |
---|---|
Knockdown Reagent: | |
Observed In: | |
Stage: | Day 4 |